JE

Jacob Effron

Partner at Redpoint Ventures

San Francisco, California

Investor
VC

Invests in

Stages:

Series B
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $25,000,000.00

Education

Work Experience

Redpoint Ventures

2020

  • Partner

    2020

    Investments: Abridge, AcuityMD, Deliverect, Garner, Ideogram, Leya, Poolside, Ramp, Scribe and Strive

Abridge

2024

  • Board Observer

    2024

Leya

2024

  • Board Member

    2024

poolside

2023

  • Investor

    2023

Ideogram

2023

  • Investor

    2023

AcuityMD

2022

  • Board Observer

    2022

Garner Health

2021

  • Board Observer

    2021

Scribe

2023

  • Investor

    2023

Ramp

2021

  • Investor

    2021

Deliverect

2021

  • Board Observer

    2021

Latest Articles

Substack•Aug. 2024

AI Builder Survey

generative AI applications
AI model switching
OpenAI and Claude models
Retrieval-Augmented Generation (RAG)
fine-tuning AI models
Substack•Jul. 2024

Sword Health CEO Virgílio (“V”) Bento on Vital Signs

Sword Health
Phoenix AI care specialist
patient engagement
AI in healthcare
healthcare innovation
Substack•Apr. 2024

Eight Key Lessons for Rocket-Shipping AI Products

AI startups
LLMs (large language models)
product adoption
team structuring
customer feedback
Substack•Feb. 2024

Investing in Abridge

Abridge
Generative AI
Clinical documentation
Healthcare technology
Physician burnout
Substack•Jan. 2024

Vital Signs Highlights

Vital Signs podcast
healthcare industry
digital health
maternity care in the US
AI in healthcare
Substack•Oct. 2023

Mark Cuban on Disrupting PBMs, Staying Curious and Using AI to Avoid NBA Fines

pharmacy industry problems
Mark Cuban Cost Plus Drug Company
price transparency in pharmaceuticals
healthcare system issues
artificial intelligence (AI)
Substack•Aug. 2023

VP of Generative AI at Adobe Alexandru Costin on The Future of Content Creation

Generative AI
Adobe
AI in content creation
Job impact of AI
Human-computer interaction
Substack•Jul. 2023

The Future of AI In Medical Diagnosis: In Conversation With PathAI CEO Dr. Andy Beck

AI in pathology
PathAI
computer vision
pharmaceutical industry
drug discovery
Substack•Jul. 2023

EleutherAI's Aran Komatsuzaki on Open-Source Models' Future and Thought Cloning

EleutherAI
open source models
artificial general intelligence
The Pile
large language models
Substack•Jul. 2023

Stanford Professor Tatsu Hashimoto on AI Biases and Improving LLM Performance

unsupervised learning
LLM training pipeline
academia's role in LLM development
compute-efficient LLMs
finetuning models
Substack•Jun. 2023

Why Databricks Bought Mosaic and The Rapidly Decreasing Costs of AI

MosaicML
Databricks acquisition
foundation models
cost reduction in training
cost reduction in inference
Substack•Jun. 2023

How Insitro Is Using AI to Create Better Medicines: In Conversation With Daphne Koller

AI in drug development
Insitro
machine learning in drug discovery
biological data
clinical data
Substack•Jun. 2023

This Billion Dollar Startup is Using AI to Design New Drugs

AI in drug development
Insitro
machine learning
biological data
clinical data
Substack•Jun. 2023

OpenAI's Product Leader Discusses Their Strategy & the Future of AI

foundation model stack
open vs. closed LLMs
AI risks
value in AI applications
LLM tooling
Substack•Apr. 2023

Optum's Evolution and Lessons from Obamacare and COVID: In Conversation with Andy Slavitt

public/private collaboration in healthcare
Optum's growth and evolution
lessons from COVID-19
Affordable Care Act (ACA)
private sector's role in healthcare
Substack•Mar. 2023

Scaling and Orchestrating Large Language Models: In Conversation With Databricks CTO Matei Zaharia

Databricks
LLMs (Large Language Models)
DSP (Demonstrate-Search-Predict Framework)
Machine Learning in Enterprises
Cloud Computing
Substack•Mar. 2023

The Future of Open vs Closed Source in AI: In Conversation With Hugging Face CEO Clem Delangue

Hugging Face
AI community
open source models
ChatGPT
closed source vs open source
Substack•Mar. 2023

How to Sell to Employers and The Future of Mental Healthcare: In Conversation with Naomi Allen

Brightline
mental health
pediatric mental health
employer benefits
healthcare technology
Substack•Feb. 2023

Using Large Language Models Effectively

Large Language Models (LLMs)
AI features
investment and experimentation with LLMs
third-party LLM providers
open source LLMs
Substack•Feb. 2023

Coming soon...

Unsupervised Learning
AI landscape
business impact
technology updates
Substack•Dec. 2022

Building a Platform Biotech and The Future of R&D: In Conversation With Chris Gibson

AI for drug discovery
Recursion Pharmaceuticals
machine learning
genetic diseases
drug development
Substack•Nov. 2022

The Evolution and Future of Healthcare Data and Building a Vertical SaaS Platform: In Conversation With Dr. Arif Nathoo

pharma software
healthcare data
Real World Evidence
R&D tools
Komodo Health
Substack•Nov. 2022

The Future of Health Systems and Increasing Healthcare Productivity: In Conversation With Dr. Bob Kocher

Affordable Care Act
healthcare productivity
healthcare costs
Bob Kocher's career journey
health systems
Substack•Oct. 2022

Using Tech to Lower Healthcare Costs and Carbon Health's Strategy: In Conversation With Eren Bali

Carbon Health
Eren Bali
EHR (Electronic Health Record)
healthcare clinics
tech strategy
Substack•Oct. 2022

Sachin Jain on Incubating Businesses and Why Health Systems Will Drive Value-Based Care

Vital Signs podcast
Nikhil Krishnan
SCAN CEO Dr. Sachin Jain
Medicare Advantage
non-profit health plans
Substack•Sep. 2022

The Changing World of Life Sciences R&D

life sciences
therapeutic modalities
cell and gene therapies
CRISPR
mRNA
Substack•Sep. 2022

Running CMS During COVID and Drug Pricing: In Conversation with Seema Verma

Seema Verma
Centers for Medicare & Medicaid Services (CMS)
COVID-19
drug pricing legislation
digital health
Substack•Aug. 2022

Improving Policy and Rural Healthcare: In Conversation with Brad Smith

Brad Smith
CareBridge
Main Street Health
Aspire
Center for Medicare and Medicaid Innovation (CMMI)
Substack•Aug. 2022

Amazon/One Medical, Galileo and Healthcare’s Future: In Conversation with Dr. Tom Lee

Amazon's acquisition of One Medical
Dr. Tom Lee's career in healthtech
Founding and running One Medical
Founding Galileo and its care model
Role of physical clinics in healthcare
Substack•Jul. 2022

Medicaid Innovation and Succeeding Under Risk: In Conversation with Dr. Mandy Cohen

Dr. Mandy Cohen
North Carolina's Department of Health and Human Services
Centers for Medicare and Medicaid Services
Aledade
value-based care
Substack•Jul. 2022

The Value Based Care Market and What's Ahead: In Conversation with Adam Boehler

healthtech
Vital Signs podcast
Adam Boehler
value-based care
risk-based businesses
Substack•Apr. 2022

Taking On Risk

health tech startups
value-based care
risk-based care models
healthcare reimbursement
patient care management
Substack•Mar. 2022

The Parallel Journeys of Fintech and Healthtech

healthtech ecosystem
fintech and healthtech parallels
venture capital in healthtech
investment trends
healthcare innovation
Substack•Feb. 2022

The Changing World of Medicare Advantage

Medicare Advantage
health insurers
enrollment projections
digital health innovation
call centers
Substack•Jan. 2022

10 Health Tech Predictions for 2022

health tech
risk-based specialty care
digital health infrastructure
social determinants of health
startup partnerships in healthcare
Substack•Nov. 2021

Vital Signs: Babylon Health Breakdown

Babylon Health
AI-based symptom triage
risk-bearing care model
Medicare patients
digital health services
Substack•Nov. 2021

Vital Signs

health tech
S-1 breakdowns
sector breakdowns
Vital Signs newsletter
Substack•Nov. 2021

How Real World Evidence is Changing Healthcare

HITECH Act
Electronic Health Records (EHR)
Real World Evidence (RWE)
Randomized Controlled Trials (RCTs)
Data standardization in healthcare
Substack•Nov. 2021

Definitive Healthcare’s S-1 Breakdown

Definitive Healthcare IPO
health tech IPOs
sales intelligence for healthcare
healthcare data platforms
competition with IQVIA and others